About This Publication:

  • Print This Page
  • Text a Friend
  • Subscribe to an RSS Feed

Sample Content 

My Liebert Connect

Sign up to stay informed--receive email notifications for this journal

Vector-Borne and Zoonotic Diseases

Editor-in-Chief: Stephen Higgs, PhD, FRES

ISSN: 1530-3667 • Published Monthly • Online ISSN: 1557-7759

Current Volume: 14

Latest Impact Factor* is 2.531

*2013 Journal Citation Reports® published by Thomson Reuters, 2014

A dynamic new author services platform
to share, measure, and enhance the impact of your research
Complimentary one-year membership with submission to this journal

For Authors

  • Manuscript Submissions
  • NIH/HHMI Wellcome Trust Policies
  • Self-Archiving Policy
  • Open Access Policy
  • Manuscript Submissions

    Mary Ann Liebert, Inc. Submission Benefits Package

    Your submission to Vector-Borne and Zoonotic Diseases provides you with robust tools and support to ensure maximum impact and readership for your work. By submitting your manuscript, you’ll receive:

    • Complimentary 12-month AuthorCite® membership
      Exclusively licensed by Mary Ann Liebert, Inc., AuthorCite® delivers a 360-degree view of your article from submission to publication to market impact. With an AuthorCite® membership, you’ll receive end-to-end manuscript submission tracking, a custom online microsite to promote you and your research, a professional suite of metrics and analytics to measure the impact of your article, 30-day OpenLink™ article sharing, and much more.
    • Rapid, rigorous peer-review and editorial attention
    • Immediate deposit to PubMed and other indexing services upon online publication
    • Exposure to thousands of thought-leaders in your field, maximizing readers, citations, and downloads
    • Fast Track online-ahead-of-print publication
    • Global availability in over 170 countries
    • Open Access publication options

    Submitting Your Manuscript

    Submitting your manuscript to Vector-Borne and Zoonotic Diseases delivers a comprehensive benefits program that ensures high-quality review of your research and maximum impact for your work. This includes a one-year membership to AuthorCite™, a robust author services platform for increasing the visibility of your research, and includes the ability to freely share your article for 30 days. Vector-Borne and Zoonotic Diseases carries a manuscript processing charge* of $49.00 USD upon submission of each new manuscript.

    Upon payment, you will be provided a Manuscript Submission Code, and will be prompted to enter this information when uploading your files to our peer-review system.  Please note:  Securing a token does not automatically create an account in our peer-review system. If you do not already have an account, you will be asked to create one before you can begin your submission.

    Submissions do not need to be completed at once. Submitting authors/agents may begin the submission process, save their work, and return to the site to complete the upload(s) at a later time. There is no limit on the number of times one can save their work and subsequently resume the submission. Doing so will not incur additional charges.

    Click here to submit your paper via our fast and user-friendly electronic submission system.

    Manuscript Revisions

    Processing charges and submission codes are NOT required for revisions to previously submitted papers. To upload a revision of a paper, the submitting author should log in to their Author Center at http://mc.manuscriptcentral.com/vbz and click on “Revised Manuscripts in Draft.” The paper will appear in this area, and the submitting author will be able to upload revised files without paying any charges or entering a submission code.

    Please be sure to follow the Instructions for Authors below on Manuscript Preparation.  Authors whose submissions do not comply with the Instructions for Authors will have their papers un-submitted so that the file(s) may be adjusted accordingly. Directions regarding the necessary corrective actions will be provided in an email to the corresponding author at the time the paper is un-submitted. The submitting author/agent will then be provided the opportunity to re-upload the corrected file(s). If a paper is un-submitted, the paper will reside in the corresponding author’s “Author Center” as a draft, and the submitting author/agent will be able to make the necessary adjustments and re-upload the paper without incurring another manuscript processing charge.  

    *The manuscript processing charge is independent of editorial decision and is non-refundable.


    Vector-Borne and Zoonotic Diseases is a peer-reviewed journal that includes articles on diseases transmitted to humans by mosquitoes, ticks, and other arthropod vectors or directly by other animals. The Journal emphasizes the following topics: ecology, entomology, microbiology, immunology, and wildlife biology, as well as other subjects relevant to the transmission of infectious diseases to humans directly from the environment or through vectors.

    A primary goal of this peer-reviewed journal is the integration of field, laboratory, and clinical sciences for the purpose of establishing causal relationships between clinical medicine and the environment that will lead to improved understanding of this group of neglected but important diseases and contribute to their successful management and prevention. The Journal develops and encourages publication standards to foster effective and reliable data collection, analysis, interpretation, and communication. The Journal does not publish articles that have been submitted elsewhere or have been previously published.


    Formats.  Original research manuscripts should not exceed 3,000 words and must be presented in the standard format described below. Short reports and case studies should not exceed 1,000 words with no more than 10 references and one table or figure. Editorials and commentaries may be on any issue relevant to the field, but must be brief and appropriately documented by data. Reviews papers, of up to 5,000 words in length, are summaries of developments in the field. All submissions are subject to peer-review. 

    To help defray the cost of printing the Journal requests page charges of $75 per printed page be paid by all authors who have funds available from research grants or from their institutions.  It should be noted that ability to pay page charges is not a prerequisite for publication in the Journal. 

    Please read all the instructions to authors before submitting.

    Authorship. All authors, including the co-authors, should be responsible for a significant part of the manuscript.  All authors and co-authors should have taken part in writing the manuscript, reviewing it, and revising its intellectual and technical content,  and all must sign  the  cover  letter  accompanying  the  manuscript.   Any author whose name appears on a paper assumes responsibility and accountability for the results.

    Preparation of Manuscripts

    Manuscripts should be submitted double-spaced and leave ample margins on both sides, top and bottom.

    Submit a running title of about 45 characters (including spaces), and the full contact information for the corresponding author. Also provide a structured abstract of no more than 300 words.


    As part of your text file, include a title page that contains the title of your paper, all authors’ names, affiliations, email addresses and keywords.

    Text.  Organize the text as follows: Introduction, Materials and Methods, Results, Discussion, Conclusions, Acknowledgments, and References.  At the first usage of a term, spell out the term and give the abbreviation or acronym in parentheses. Thereafter, use the abbreviation/acronym alone. Use generic names for drugs where possible. If you wish to use a proprietary drug name, the first time it appears use the generic name followed by the proprietary name, manufacturer, and city in parenthesis. If propriety names must be used, include trademark information. Scientific names for species must appear with genus spelled in full on first occurrence and abbreviated thereafter. Family names should appear on first occurrence of uncommon species.

    Tables. Submit each table, with its title, as a separate file. Use Arabic numerals to number tables. Details of experimental conditions should be included in the table footnotes. Table legends and footnotes should be double-spaced.

    Acknowledgments. The author should acknowledge only those people and institutions that have made significant contributions to the study. Details of sources of funding must be given and any potential conflicts of interest declared, e.g., financial, personal, political or academic. 

    Disclosure Statement  Immediately  following  the Acknowledgments  section,  include  a  section  entitled “Author Disclosure Statement.”

    In this portion of the paper, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the paper is being reviewed and will not influence the editorial decision. 

    Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at http://www.icmje.org/index.html#conflicts for further guidance. 


    If no conflicts exist, the authors must state “No competing financial interests exist.”

    References. The references should be cited in the text using the name/date system. The reference list at the end of the paper should be double-spaced and organized alphabetically by name and year. List only the first four authors followed by "et al." For accepted papers not yet published, cite the journal and add "in press."  If references to personal communications or unpublished data are used, cite them parenthetically in the text, not in the references. Sources for personal communications must provide written approval at the time of submission. Authors are responsible for the accuracy of references. References should be presented as shown below:

    Journal example: Chadee DD, Kitron  U. Spatial and temporal patterns of imported malaria cases and local transmission in Trinidad. Am J Trop Med Hyg 1999;61:513-517.
    Book example: Fish D. Population ecology of Ixodes dammini. In: Ginsberg, H, ed. Ecology and Environmental Management of Lyme Disease. New Jersey: Rutgers University Press; 1993:25-42.

    Correspondence address. After the references, provide the name, address, and e-mail of the person to whom all correspondence should be directed.

    Please do not upload a PDF of your text file.



    Prepare a separate list of figure legends, double-spaced, at the end of the manuscript. Magnifications should be included when appropriate.  

    Please follow these guidelines for submitting figures.


    • Do NOT embed art files into a Word or PDF document.
    • Line illustrations should be submitted at a minimum of 900 dpi.
    • Halftones and color should be submitted at a minimum of 300 dpi.
    • Black and White art  must be submitted as grayscale—not RGB.
    • Save as either TIFF or EPS files.
    • Color art must be saved as CYMK—not RGB.
    • PowerPoint and Excel files cannot be uploaded.


    Please name your artwork files with the submitting authors name i.e. SmithFig1.tif,  SmithTable2.tif  etc.  Authors who do not follow these guidelines may experience a delay in processing.




    Please do NOT upload a single PDF file containing all of the text, figure, and table files of your paper. Once  all  of  your  files  are  uploaded on  to Manuscript Central, the system will automatically create a PDF proof for you.



    Converting Word or Excel files: Perhaps the best and easiest way to convert Word or Excel files into a format which is suitable for print is to scan them using the below guidelines:

    • All files should be scanned at 100% size
    • 300 dpi
    • Final color mode: cmyk
    • Save file as: .tif or .eps
    • If you need directions on how to convert a Power Point slide to acceptable format go to Www.liebertpub.com/MEDIA/pdf/ppconvert.pdf


    Figures, tables, and text taken from other sources must be accompanied by a written statement from both author and publisher granting permission for reproduction. Include written permission from authors to cite unpublished data or papers still in press.


    Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate. 


    The Journal is published by Mary Ann Liebert, Inc.,140 Huguenot Street, New Rochelle, NY 10801-5215.  Telephone: (914) 740–2100; fax: (914) 740–2101.; E-mail: info@liebertpub.com; Web site: www.liebertpub.com


  • NIH/HHMI Wellcome Trust Policies

    NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.

  • Self-Archiving Policy

    Mary Ann Liebert, Inc. is a "blue" publisher (as defined by Sherpa), as we allow self-archiving of post-print (ie final draft post-refereeing) or publisher's version/PDF.

    In assigning Mary Ann Liebert, Inc. copyright, the author retains the right to deposit such a 'post-print' on their own website, or on their institution's intranet, or within the Institutional Repository of their institution or company of employment, on the following condition, and with the following acknowledgement:

    This is a copy of an article published in the [JOURNAL TITLE] © [year of publication] [copyright Mary Ann Liebert, Inc.]; [JOURNAL TITLE] is available online at: http://online.liebertpub.com.

    Authors may also deposit this version on his/her funder's or funder's designated repository at the funder's request or as a result of a legal obligation, provided it is not made publicly available until 12 months after official publication.

  • Open Access Policy

    Choose Liebert Open Access Option!

    Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) Option.

    Your investment guarantees:

    • Immediate, unrestricted global access in 170 countries
    • Maximum visibility for increased readers, citations, and downloads
    • Targeted email announcement highlighting your article to thousands of thought-leaders in your field
    • Rapid, rigorous peer-review and editorial attention
    • Fast Track online-ahead-of-print publication
    • Immediate upload to PubMed Central and other internationally recognized repositories*
    • Recognition on online Table of Contents with exclusive OA icon
    • Compliance with OA funding mandates with no embargo period
    • Savings on future OA article publication
    • Complimentary membership in AuthorCite®, the author services platform exclusively licensed by Mary Ann Liebert, Inc. that delivers the tools you need to maximize your professional impact.

    These valuable benefits are included with a one-time article processing charge (APC). APC charge varies based on journal, membership, and subsequent submissions.

    Contact openaccess@liebertpub.com for questions on article Open Access options. 

     *Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.


    Is your Institution a member of the Liebert Author Advocacy Program?

    The Liebert Author Advocacy Program (LAAP) provides valuable membership benefits for OA publication to institutional and funding organizations, and supports global funding mandates.  Authors who are affiliated with LAAP member institutions receive all the valuable benefits of Liebert OA article publication, and more.

    For details, and to recommend institutional membership visit: www.authoradvocacy.com or contact laap@liebertpub.com 




The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Recommended Publications

You may be interested in the following publications:

    Biosecurity and Bioterrorism: Biodefense Strategy, Practice,
    and Science

    Biosecurity and Bioterrorism: Biodefense Strategy, Practice,
    and Science

    The peer-reviewed journal providing essential guidance for the protection of society against bioweapons, and is a key resource for policy makers, scientific experts, and government officials.

    Foodborne Pathogens and Disease

    Foodborne Pathogens and Disease

    Spanning an array of issues from "farm-to-fork," this Journal bridges the gap between science and policy to reduce the burden of foodborne illness worldwide.

    Viral Immunology

    Viral Immunology

    The only journal reporting on all aspects of the rapidly growing field of viral immunology, with comprehensive coverage of immune responses to viral infections from basic mechanisms to clinical applications.

Browse All Publications »